Inventor
KOSLOWSKI MICHAEL
DE53 patents
⚠️ This page may combine multiple inventors who share the name “KOSLOWSKI MICHAEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GANYMED PHARMACEUTICALS AG
20 patentsUS7527933B2May 5, 2009
Genetic products differentially expressed in tumors and the use thereof
GANYMED PHARMACEUTICALS AG115 citations96
US7785801B2Aug 31, 2010
Identification of surface-associated antigens for tumor diagnosis and therapy
GANYMED PHARMACEUTICALS AG14 citations91
US10233253B2Mar 19, 2019
Antibodies for treatment of cancer expressing claudin 6
GANYMED PHARMACEUTICALS AG7 citations83
US9775785B2Oct 3, 2017
Antibody to genetic products differentially expressed in tumors and the use thereof
GANYMED PHARMACEUTICALS AG5 citations81
US8961980B2Feb 24, 2015
Monoclonal antibodies for treatment of cancer
GANYMED PHARMACEUTICALS AG5 citations79
US9475867B2Oct 25, 2016
Monoclonal antibodies for treatment of cancer
GANYMED PHARMACEUTICALS AG3 citations73
US8354104B2Jan 15, 2013
Monoclonal antibodies for treatment of cancer
GANYMED PHARMACEUTICALS AG3 citations63
US7429461B2Sep 30, 2008
Genetic products differentially expressed in tumors and use thereof
GANYMED PHARMACEUTICALS AG2 citations63
US10919974B2Feb 16, 2021
Antibodies for treatment of cancer expressing claudin 6
GANYMED PHARMACEUTICALS AG0 citations61
US9932401B2Apr 3, 2018
Antibodies specific for claudin 6 (CLDN6)
GANYMED PHARMACEUTICALS AG1 citations61
US9902778B2Feb 27, 2018
Cancer therapy using CLDN6 target-directed antibodies in vivo
GANYMED PHARMACEUTICALS AG1 citations61
US11473085B2Oct 18, 2022
Methods and compositions for diagnosis and treatment of cancer
GANYMED PHARMACEUTICALS AG1 citations57
US10596256B2Mar 24, 2020
Monoclonal anti-GT 468 antibodies for treatment of cancer
GANYMED PHARMACEUTICALS AG0 citations52
US10414824B2Sep 17, 2019
Genetic products differentially expressed in tumors and the use thereof
GANYMED PHARMACEUTICALS AG0 citations52
US10125196B2Nov 13, 2018
Monoclonal antibodies for treatment of cancer
GANYMED PHARMACEUTICALS AG0 citations52
US9919036B2Mar 20, 2018
Identification of tumor-associated antigens for diagnosis and therapy
GANYMED PHARMACEUTICALS AG0 citations52
US9453260B2Sep 27, 2016
Genetic products differentially expressed in tumors and use thereof
GANYMED PHARMACEUTICALS AG0 citations52
US10844133B2Nov 24, 2020
Cancer therapy using CLDN6 target-directed antibodies in vivo
GANYMED PHARMACEUTICALS AG0 citations51
US10745477B2Aug 18, 2020
Antibodies specific for claudin 6 (CLDN6)
GANYMED PHARMACEUTICALS AG0 citations51
US10036753B2Jul 31, 2018
Identification of surface-associated antigens for tumor diagnosis and therapy
GANYMED PHARMACEUTICALS AG0 citations51
SAHIN UGUR
17 patentsUS8946388B2Feb 3, 2015
Monoclonal antibodies for treatment of cancer
SAHIN UGUR41 citations94
US8586047B2Nov 19, 2013
Genetic products differentially expressed in tumors and the use thereof
SAHIN UGUR20 citations93
US9487584B2Nov 8, 2016
Antibodies specific for claudin 6 (CLDN6)
SAHIN UGUR19 citations92
US8637012B2Jan 28, 2014
Genetic products differentially expressed in tumors and the use thereof
SAHIN UGUR18 citations92
US8088588B2Jan 3, 2012
Genetic products differentially expressed in tumors and the use of thereof
SAHIN UGUR17 citations92
US9718886B2Aug 1, 2017
Cancer therapy using CLDN6 target-directed antibodies in vivo
SAHIN UGUR13 citations91
US9321842B2Apr 26, 2016
Antibodies for treatment of cancer
SAHIN UGUR14 citations91
US10738355B2Aug 11, 2020
Individualized vaccines for cancer
SAHIN UGUR41 citations90
US9175088B2Nov 3, 2015
Identification of tumor-associated markers for diagnosing or monitoring ovarian cancer
SAHIN UGUR8 citations84
US8975375B2Mar 10, 2015
Identification of tumor-associated antigens for diagnosis and therapy
SAHIN UGUR5 citations84
US9216218B2Dec 22, 2015
Monoclonal antibodies for treatment of cancer
SAHIN UGUR11 citations81
US9637548B2May 2, 2017
Methods and compositions for diagnosis and treatment of cancer
SAHIN UGUR2 citations73
US9090940B2Jul 28, 2015
Identification of surface-associated antigens for tumor diagnosis and therapy
SAHIN UGUR3 citations62
US8716455B2May 6, 2014
Genetic products differentially expressed in tumors and use thereof
SAHIN UGUR0 citations52
US8551490B2Oct 8, 2013
Genetic products differentially expressed in tumors and use thereof
SAHIN UGUR0 citations52
US8088913B2Jan 3, 2012
Compositions and methods for therapy and diagnosis of cancer
SAHIN UGUR0 citations52
US9809815B2Nov 7, 2017
Methods and compositions for diagnosis and treatment of cancer
SAHIN UGUR0 citations49
BIONTECH AG
8 patentsUS9533043B2Jan 3, 2017
Identification of surface-associated antigens for tumor diagnosis and therapy
BIONTECH AG7 citations83
US9194004B2Nov 24, 2015
Identification of surface-associated antigens for tumor diagnosis and therapy
BIONTECH AG6 citations82
US10724103B2Jul 28, 2020
Identification of surface associated antigen FLJ31461 for tumor diagnosis and therapy
BIONTECH AG1 citations71
US10253373B2Apr 9, 2019
Identification of tumor-associated markers for diagnosis and therapy
BIONTECH AG1 citations62
US9637794B2May 2, 2017
Genetic products differentially expressed in tumors and use thereof
BIONTECH AG0 citations52
US10302647B2May 28, 2019
Identification of surface-associated antigens for tumor diagnosis and therapy
BIONTECH AG0 citations51
US10526387B2Jan 7, 2020
Tumor vaccination involving a humoral immune response against self-proteins
BIONTECH AG0 citations49
US9617321B2Apr 11, 2017
Tumor vaccination involving a humoral immune response against self-proteins
BIONTECH AG0 citations49
Türeci Özlem
2 patentsGANYMED PHARMACEUTICALS GMBH
2 patentsTRON TRANSLATIONALE ONKOLOGIE AN DER UNIV DER JOHANNES GUTENBERG UNIV MAINZ GGMBH
1 patentShowing the top 50 of 53 patents by PatentIndex Score.